Scientists Develop Alzheimer’s Detection Test to Prevent the Disease
Scientists discovered that a teaspoon of saliva is enough to predict whether an individual is destined to develop Alzheimer’s disease, according to a new study published on March 10, 2018.
A team of scientists led by Dr. McGreen, CEO of Vancouver-based Aurin Biotech, discovered that peptide Abeta 42 is not made in the brain alone, as the preconceived notion. It is made in all the organs of the human body and is secreted by the submandibular glands. They found that it was possible to predict the possibility of the acquiring of Alzheimer’s disease in an individual’s lifetime, by simply examining a teaspoon full of their saliva. This in turn, would help people take preventive measures early on in life.
The team suggested that people consume non-prescription non-steroidal drugs (NSAIDs) such as ibuprofen to prevent the onset of Alzheimer’s.
“What we’ve learned through our research is that people who are at risk of developing Alzheimer’s exhibit the same elevated Abeta 42 levels as people who already have it; moreover, they exhibit those elevated levels throughout their lifetime so, theoretically, they could get tested anytime. Knowing that the prevalence of clinical Alzheimer’s disease commences at age 65, we recommend that people get tested ten years before, at age 55, when the onset of Alzheimer’s would typically begin. If they exhibit elevated Abeta 42 levels then, that is the time to begin taking daily ibuprofen to ward off the disease.” said Dr. McGeen, lead author of the study.
Most therapies have failed to avoid the disease progression, however, the newly developed test is simply one to help identify if a person is fated to develop Alzheimer’s disease, long before it could develop. The onset can further be avoided by a solution that does not require prescription or visits to a doctor.
You may be interested
Lysosomal Acid Lipase (LAL) Deficiency Treatment Market to Witness Robust Expansion Throughout the Forecast Period 2017 – 2025Albert R - October 22, 2018
CMI released a new market study on 2017-2025 Lysosomal Acid Lipase (LAL) Deficiency Treatment Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through…
Anxiety Disorders and Depression Treatments Anxiety Disorders and Depression Treatments Market is forecasted to witness a thriving growth by 2025Albert R - October 22, 2018
CMI released a new market study on 2017-2025 Anxiety Disorders and Depression Treatments Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages…
Surgical Sutures Market 2018: Record Overwhelming Hike in Revenues by 2026Albert R - October 22, 2018
CMI released a new market study on 2017-2025 Surgical Sutures Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to…